In Today’s News

Your Options Checklist Is Expiring [sponsor]

AbbVie’s Dividend Is Growing Because Its Drugs Are Growing

AbbVie's Dividend Is Growing Because Its Drugs Are Growing

The answer is in the revenue lines, not the EPS adjustments.Second-quarter worldwide net revenues came in at $16.99 billion, an increase of 10.2 percent on a reported basis. That number matters because it is built on a very different foundation than the Humira era. In Q2, Skyrizi sales climbed 24.4% to $5.505 …

61% of Americans Worry America Could be on the Verge of Another Civil War [sponsor]
Today, more than half of America thinks a civil war is likely. Former CIA Advisor Jim Rickards agrees. He just uncovered a fascinating plot by Trump to keep the Democrats out of the White House until 2033. And while he believes it could be successful, it could also trigger America’s Second Civil War. For the full story, click here.

Binance Is Frozen. Here Is What Bitcoin Needs to Do Before the Open.

Bitcoin remained below $80,000 as traders responded to the breach and a wave of forced position closures, trading near $78,000. BTC dipped as low as the mid-$76,000s during the session but later recovered above $78,000. Ether fell about 5% to around $2,200, while BNB slid roughly 7%. Crypto market liquidation …

Don’t Buy Bitcoin (Do This Instead)

A former hedge fund manager whose firm Barron’s ranked in the top 1% worldwide says buying Bitcoin is the wrong move.

His readers have had the chance to collect $4,898… $11,145… and even $17,350 from Bitcoin’s moves without owning a single coin.

Now he’s revealing the whole strategy, free.

Tech Is Being Sold on Month-End. Tuesday Changes the Calculus.

“Inflationary pressures have started to resurface and will likely keep the Federal Reserve in tightening mode, just as an increasing share of the AI buildout needs to be financed by debt issuance,” said Wolf von Rotberg, an equity strategist at Bank J Safra Sarasin. That framing is clean. It may also be incom …

Play the Biggest IPO Boom in History And Get Paid Monthly [sponsor]
2026 could be the biggest IPO year ever: SpaceX just went public, and Anthropic and OpenAI could be next. Income expert Tim Plaehn found a much simpler way to play the wave: a little-known fund paying a 20% annualized distribution rate, up to $1,104 a month. Click here to see Tim’s IPO Income play.

Intel Beat Every Q3 Target. Then Its PC Business and a Factory Blast Hit the Stock.

Q3 revenue came in at $16.5 billion, up 21% year-over-year, with non-GAAP EPS of $0.52. That EPS figure beat the $0.40 consensus by 30%. The headline numbers were clean. The market did not care.Intel expects fourth-quarter revenue between $15 billion and $16 billion, below analysts’ average estimate of about …

Elon Musk’s New Invention Will Blow You Away

Elon Musk did it again! After self-driving cars…

Reusable rockets that land themselves…

And brain chips that let paralyzed people control computers with their minds…

Elon just filed this patent (click here and see it for yourself) to protect his new invention…

A new form of AI so powerful he called it an “infinite money glitch.”

And it could help send shares of this little-known Elon Musk supplier to the moon.

This simple trade happens 3-5x’s a week, Options expert shares his strategy. [sponsor]

The One Part Nobody Can Build Fast Enough [sponsor]

How to master the “Retirement Trade” [sponsor]

DISCLAIMER
This is a paid advertisement for informational and educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Stocks Now is operated by Investing Media Solutions, LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Investing Media Solutions, LLC (“IMS”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual.This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.b>

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution.Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment.Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

For full policies, see our: Disclaimer | Privacy | Terms

Trading Stocks Now
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

AbbVie’s Dividend Is Growing Because Its Drugs Are Growing

In Today’s News

Your Options Checklist Is Expiring [sponsor]

AbbVie’s Dividend Is Growing Because Its Drugs Are Growing

Binance Is Frozen. Here Is What Bitcoin Needs to Do Before the Open.

Tech Is Being Sold on Month-End. Tuesday Changes the Calculus.

Intel Beat Every Q3 Target. Then Its PC Business and a Factory Blast Hit the Stock.

You Might Also Like

This simple trade happens 3-5x’s a week, Options expert shares his strategy. [sponsor]

The One Part Nobody Can Build Fast Enough [sponsor]

How to master the “Retirement Trade” [sponsor]

More From Author

Regeneron Reports Q3 2026 With a Clearer Dupixent Profit Share

Intel Beat Every Q3 Target. Then Its PC Business and a Factory Blast Hit the Stock.

Tech Is Being Sold on Month-End. Tuesday Changes the Calculus.

Intel Beat Every Q3 Target. Then Its PC Business and a Factory Blast Hit the Stock.

Regeneron Reports Q3 2026 With a Clearer Dupixent Profit Share

Live Market Pulse

Recent Posts

Categories

In Today’s News

You Might Also Like

Live Market Pulse

Sign up for our free Trading Stocks Now Newsletter!

Recent Posts

Categories